Moreover, treatment with 2,5-dimethylcelecoxib (DMC), a microsomal prostaglandin E synthase-1 (mPGES-1) inhibitor, was found to suppress HCC growth and PD-L1 expression. The gene discussed is CD274; the disease is hepatocellular carcinoma.